Guttural pouch mycosis (GPM) is a rare but potentially life-threatening condition in horses. GPM is caused by a fungal invasion into the mucosal lining of the guttural pouches and, frequently, the associated neurovascular structures. Although several species of fungi have been associated with this disease, Aspergillus spp. appear to be the most common isolated from the guttural pouches. However, it remains unclear which are the predisposing factors leading to the development of the infection. The objectives of the present study were to experimentally reproduce an infection by Aspergillus fumigatus and to follow the natural evolution of the mycosis. Eight guttural pouches from four horses were experimentally infected by endoscopy-guided intrapouch inoculation of A. fumigatus culture. Horses were monitored for clinical signs and development of fungal plaques through endoscopic examination. Mycotic lesions were observed in all the horses and a spontaneous regression was observed within 15-28 days. No development of clinical signs was noticed. In conclusion, we were able to induce the development of mycotic lesions and to observe a natural regression of these lesions without clinical signs.
Introduction
Guttural pouches are paired air-filled ventral diverticuli of the Eustachian tubes extending from the nasopharynx to the middle ear in horses. 1 The guttural pouches may play a role in controlling pressure equilibration across the tympanic membrane, contributing to air warming, creating a resonating chamber for vocalization. 2 It has also been proposed that guttural pouches are involved in the regulation of the temperature of arterial blood by cooling down the circulation to the brain of horses. 2 Due to numerous adjacent neurological and vascular structures associated with the guttural pouches, the diseases of their membranes can induce various neurological signs. Overall, diseases of guttural pouches are infrequent but many of the observed clinical signs, such as dysphagia and epistaxis, can be caused by fungal infections. 3 Guttural pouch mycosis (GPM) was first described in 1868. 4 It is a rare condition characterized by the development of fungal plaques on the mucosal lining of the guttural pouches as well as the associated neurovascular structures. Involvement of the vessels and nerves can lead to hemorrhage, secondary to rupture of the arteries, and dysphagia, making this disease potentially life-threatening ( Figure 1 ). Despite its clinical importance, pathogenesis remains poorly understood, partly in absence of relevant animal models. A wide number of bacterial and fungal organisms are common inhabitants of the equine upper airways and guttural pouches. Although several species of fungi have been associated with this disease, Aspergillus nidulans and A. fumigatus appear to be the most commonly involved. 5 To our knowledge, species of fungi that have been already isolated from an equine guttural pouch are Aspergillus versicolor, A. nidulans, A. fumigatus, A. niger, Mucor sp., and Scopulariopsis sp. 5 The underlying mechanisms associated with pathogenicity of these fungi in horses that are not debilitated or immunosuppressed are still unknown. Some predisposing factors have been reported such as infection of the upper respiratory tract, 6 presence of an aneurism of the internal or external carotid arteries, 7 lesion of the soft tissue on the ventral side of the tympanic bulla, 8 erratic larval migration 9 or prolonged treatment with antimicrobials or corticosteroids. 6 There is no apparent sex, breed, age, or geographic predisposition to this disease. Affected horses are generally mature, but two cases of a 5-month old and a 6-month old foal have been reported. 10, 11 Most of the lesions are usually unilateral and they develop mainly on the roof of the medial compartment over the petrous temporal bone and in the distal segment of the internal carotid artery 3 or, less frequently, on the lateral wall of the lateral compartment where the external carotid artery and maxillary artery are located. 12, 13 Lesions on the medial wall of the medial compartment can erode through the septum to affect the other pouch. If untreated, guttural pouch mycosis may result in an unpredictable fatal hemorrhage or irreversible neurological lesions. The aim of treatment is to prevent a life-threatening bleeding occluding the damaged artery.
The objectives of the present study were to reproduce the fungal infection and to follow the evolution of the infection in order to create a study model for the disease and to further elucidate the pathogenesis and course of GPM in horses.
Materials and methods

Animals
Four (A, B, C, D) university-owned adult horses (two geldings and two mares) were used in the study. Horses were between six and 13 years of age with a mean body weight of 527 kg. All horses were healthy as determined based on physical examination, cell blood count and biochemistry analysis. During the study, horses were housed in paddocks and fed with hay.
Aspergillus fumigatus inoculum
The strain CBS 144.89, initially isolated in France from a human patient with invasive aspergillosis, was used for the experiment. All mycological cultures were done on malt agar plates supplemented with chloramphenicol (5 mg/l) and incubated at 37
• C for up to 10 days. Spores were subsequently harvested by flooding the plates with sterile phosphate-buffered saline (PBS) containing 0.01% (vol/vol) Tween 20 (PBST). The conidia were concentrated by centrifugation at 3500 g for 30 min and counted using a Malassez counting chamber.
Experimental inoculation
Endoscopic evaluation of the eight guttural pouches of the four horses was performed prior to the inoculation to assess the absence of abnormality. Each guttural pouch was experimentally infected with approximately 9.10 8 A. fumigatus conidia in a 15 ml final volume of sterile physiologic saline solution by endoscopy-guided intrapouch inoculation. In three pouches (from horses B, C, and D), a surgical coil embolization of the internal carotid artery had been previously performed for an unrelated study. Endoscopic examination of the guttural pouches was performed using a flexible videoendoscope (Storz 60814PKS; 140 cm long and 9 mm tip diameter, working channel diameter 2.2 mm).
Experimental design
The methods used for induction of Aspergillus infection in horses were developed on the basis of the avian model. 15 Horses were preconditioned before inoculation by administration of systemic dexamethasone (Dexadreson R ) at 0.1 mg/kg, IM, q24h on 5 consecutive days prior to Aspergillus inoculation. Thirty ml (17.5 mg) of hydrocortisone aceponate (Cortavance R ) were locally applied just before the fungal inoculation twice every 48 h, in all the guttural pouches. The inoculation was performed with a sterile cannula through the endoscope-working channel. Horses were monitored for onset of clinical signs and development of fungal plaques. Monitoring include twice daily clinical signs assessment (heart rate, respiratory rate, temperature, nasal discharge or epistaxis, respiratory abnormalities, dysphagia, ocular abnormalities) and endoscopic examination performed every 48 h for 14 days and then twice weekly for the following 21 days. Blood samples (10 ml) were collected on EDTA tube and submitted for a complete blood count on day 0, day 5, and day 15.
Cytological and mycological analysis
On day 10, a lavage of each guttural pouch was performed using 10 ml of sterile physiologic saline solution. Samples of the fluid were transferred immediately into EDTA Vacutainer tubes and submitted for cytological examination. Guttural pouch lavage slides were prepared using an automatic slide stainer (Wescor 7150 Aerospray) and the May-Grundwald Giemsa staining. Samples of the fluid were also used for mycological culture (on Sabouraud dextrose agar plates supplemented with chloramphenicol and incubated at 37
• C for four days). A subset of strains was subcultured and genotyped by Multi Locus VNTR (Variable Number Tandem Repeats) Analysis. 16 
Ethics statement
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Results
All the horses completed the study
Macroscopic lesions
Endoscopic examination revealed the presence of diffuse or circumscribed mycotic lesions affecting all the eight guttural pouches (Figure 2) . In all cases, lesions were present in the medial and lateral compartment. The pouches presenting an embolization equally developed fungal plaques. The fungal lesions spontaneously regressed in all Note: The lesions are defined as -for no lesions; + for hyperemic inflammatory mucosa, ++ for mild amount of plaques with pus accumulation, +++ for moderate amount of plaques with pus accumulation, ++++ for severe amount of plaques with pus accumulation, - * for mucosal fibrosis of the pouch after complete regression of the mycotic plaques. B1, C2, D1 are embolized guttural pouches.
cases within 15 to 28 days (Table 1) with signs of remodeling with mucosal fibrosis in the scaring tissue. There were no differences between the three embolized pouches and the five nontreated ones in terms of time course, nature of the lesions, or their spontaneous regression (Table 1) .
Cytological observations
The presence of A. fumigatus was confirmed by direct visualization of filaments and fungal spores at cytological examination in all cases.
Mycological cultures
Mycological cultures were positive with a large number of colonies of A. fumigatus. All the strains (n = 15) collected from the horses presented the same MLVA genotype as that of the reference strain (CBS 144.89) used for the experimental infection. None of the horses exhibited any clinical signs.
Discussion
In the present study, we experimentally reproduced mycotic plaques by intra-pouches inoculation of A. fumigatus, with appearance of compatible lesions as early as 2 days postinfection. The experimentally induced lesions were similar to the typical fungal plaques seen in naturally infected horses. Interestingly, despite the cytological and mycological confirmation of the presence of the pathogen and the typical localization of the lesions, infected horses showed no clinical signs of guttural pouch mycosis. The lesions naturally disappeared within 15-28 days postinfection with signs of fibrosis in the scarring tissues.
Guttural pouch mycosis is an opportunistic infection requiring predisposing factors and an appropriate environment to develop. In absence of experimentally induced models, the mechanisms leading to this disease are unclear. The pretreatment of the horses using corticosteroids was performed based on experimental reproduction of aspergillosis in pigeons. 15 Various combinations of immunosuppressive agents, schedules, and doses have been proposed but cyclophosphamide, a DNA alkylating agent that interferes with cellular replication, and corticosteroids are the most commonly used immunosuppressant. 17 The debate about multiple aspects of the development and evolution of guttural pouch mycosis is still open. One of the clinical manifestations that is not fully understood is why the infection is generally occurring in only one pouch. While most of the studies of guttural pouch mycosis described cases with only unilateral infections, there were some reports of bilateral involvement. 10, [18] [19] [20] In most of the cases, the possible explanation was the extension of the disease through the injured medial septum. Another unresolved question regards the most common localization of the lesions. Typically, the roof of the medial compartment or, less frequently, the lateral wall of the lateral compartment are involved but the underlying mechanism is not fully understood. Guttural pouch mycosis in horses can be defined as a noninvasive condition because there is no systemic spread of the infection. The involvement of neurovascular structures is believed to be secondary to the inflammation of the tissues caused by the infection more than the direct effect of the fungi themselves on the vascular wall. That is the reason why we believe that the infection remains local.
An interesting finding in the present study is the development of the infection in the three pouches that presented an embolization of the internal carotid artery. The authors are aware of no case reports of naturally occurring aspergillosis after embolization surgery. A potential explanation is that, in our model of experimentally induced guttural pouch mycosis, the infectious dose was very high and probably do not correspond to natural condition, even though heavy environmental contamination by Aspergillus fungi can be detected in some stables.
Normally, opportunistic fungi, such as Aspergillus, are present in the equine respiratory tract, and they can be found in soil and feeding products, but to establish the infection, a debilitated or immunocompromised host is required. The impossibility to trigger the disease without an immune-suppressant therapy is sustained by the results of avian study. 15 Furthermore, the development of a guttural pouch mycosis secondary to viral or bacterial infections or to stress factors, such as transport, can accentuate the importance of the immunosuppression in the pathogenesis of the disease.
Additionally, multiple factors have been proposed as predisposing or risk factors. Contaminated feed has been suggested as a possible source of fungal spores, 21 although there are few studies supporting this theory. In one study, a case of guttural pouch mycosis followed by a mycotic encephalitis caused by an impaction with an Aspergilluscontaminated feed supplement has been described. 22 In human medicine, the environmental charge of Aspergillus has been implicated in the pathogenesis of aspergillosis. Various studies demonstrated the correlation between an increase density of conidia of nonpathogenic and pathogenic fungi in the air and an outbreak of Aspergillus infection, especially around building construction areas. [23] [24] [25] [26] Nevertheless, other studies were not able to establish any significant association. 27, 28 To our knowledge, no studies on the subject have been published in equine veterinary medicine. The spontaneous regression of the lesions reported in the present study might be due to the lack of environmental contamination compared to natural infections where horses undergo a possible continuous exposition to fungal organisms.
The results of our study should be interpreted taking into account some limitations. The double instillation to induce the infection, locally and systemically: it would be interesting to infect all the horses once before the immunosuppression therapy to better assess the role of the immune defenses in preventing the infection and to evaluate the possible development of lesions after a single instillation. To the authors' knowledge, A. fumigatus clinical isolates coming from equine cases have never been genotyped and we do not know whether isolates from equine-associated cases of guttural pouch mycosis bear similarities to the humanassociated strain of invasive A. fumigatus used in this study. Another complication is the inability to differentiate between local and systemic immunosuppression because of the combination of the corticosteroid therapy used in this study. In future research, a local installation alone of corticosteroids should be considered.
In the present study we successfully reproduced mycotic lesions after experimental inoculation of A. fumigatus conidia in the guttural pouches of horses and we were able to observe a spontaneous regression of the lesions without any clinical signs.
Many questions remain unanswered about the epidemiology and pathogenesis of guttural pouch mycosis in horses. In addition, an epidemiological study investigating seasonal changes and geographical distribution of the clinical cases might be useful. Other interesting aspects of this disease, worth being investigated, could be the relevance of other Aspergillus species (especially A. nidulans) in the development of the infection and the feature of the disease in donkeys. 29 
